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ABSTRACT  19 
We introduce atomic layer deposition (ALD) as a novel method for the ultrathin coating 20 
(nanolayering) of minitablets. The effects of ALD coating on the tablet characteristics and taste 21 
masking were investigated and compared with the established coating method. Minitablets 22 
containing bitter tasting denatonium benzoate were coated by ALD using three different TiO2 23 
nanolayer thicknesses (number of deposition cycles). The established coating of minitablets was 24 
performed in a laboratory-scale fluidized-bed apparatus using four concentration levels of 25 
aqueous Eudragit® E coating polymer. The coated minitablets were studied with respect to the 26 
surface morphology, taste masking capacity, in vitro disintegration and dissolution, mechanical 27 
properties, and uniformity of content. The ALD thin coating resulted in minimal increase in the 28 
dimensions and weight of minitablets in comparison to original tablet cores. Surprisingly, ALD 29 
coating with TiO2 nanolayers decreased the mechanical strength, and accelerated the in vitro 30 
disintegration of minitablets. Unlike previous studies, the studied levels of TiO2 nanolayers on 31 
tablets were also inadequate for effective taste masking. In summary, ALD permits a simple and 32 
rapid method for the ultrathin coating (nanolayering) of minitablets, and provides nanoscale-33 
range TiO2 coatings on porous minitablets. More research, however, is needed to clarify its 34 
potential in tablet taste masking applications. 35 
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ABBREVIATIONS 38 
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MCC Microcrystalline cellulose 40 
HPC Hydroxypropyl cellulose 41 
SPB Sodium phosphate buffer 42 
ACN Acetonitrile 43 
HPLC High performance liquid chromatography 44 
RT Room temperature 45 
RH Relative humidity 46 
RSD Relative standard deviation 47 
SEM Scanning electron microscope 48 
SEM-EDS Scanning electron microscope with energy dispersive spectroscopy 49 
1. INTRODUCTION 50 
For tablets, polymer film coating is still the most widely used and efficient taste masking 51 
technique in the pharmaceutical industry (Ayenew et al., 2009; Joshi and Petereit, 2013; Sohi et 52 
al., 2004). In addition to taste masking purposes, polymer film coating of tablets offers a variety 53 
of practical advantages that contribute to their therapeutic effect, as well as ensure patient 54 
compliance and tablet product stability throughout their shelf life (Bruce et al., 2011; Felton, 55 
2007; Joshi and Petereit, 2013; Pearnchob et al., 2003; Siepmann et al., 2013). With polymer 56 
film coating, however, sufficient taste masking and drug release control demand relatively thick 57 
polymer films, and consequently, the application of large amounts of polymers (Joshi and 58 
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Petereit, 2013). The conventional film coating methods are associated also with laborious, 59 
expensive and technical expertise demanding material selection and process development, a lot is 60 
required also from coated tablet core and coating formulation design (Joshi and Petereit, 2013). 61 
Thus, the pharmaceutical industry is continually searching for new effective and inexpensive 62 
coating approaches for tablet taste masking and palatability improvement. 63 
Atomic layer deposition (ALD) is a surface controlled, self-limiting layer-by-layer proceeding 64 
coating method for depositing ultra-thin, high quality and conformal thin films, these even on 65 
high aspect ratio structures (George, 2010). ALD is commonly used in microelectronics and 66 
nanotechnology applications, in functions, where miniaturization of structures requires the 67 
control of film thickness at atomic level (George, 2010; Puurunen, 2005). Consequently, the 68 
important features of ALD regard surface protection, modification, and functionalization, these 69 
in a number of applications benefiting from the characteristics of ALD (George, 2010). In 70 
pharmaceuticals, the moisture protective element of ALD coating has been already utilized for 71 
nano- and micro-sized drug particles (Carlsson et al., 2016). The ALD technique has been 72 
successfully applied also in the design of larger-sized, single particles intended for 73 
pharmaceutical powder applications (Hoppu et al., 2015). Here, the present situation is more than 74 
inspiring, since the thin film technology combined with material science could lead to new 75 
pharmaceutical manufacture and formulation options for fabricating the protective coatings on 76 
single drug particles. Bringing such approach to life science markets to serve the evolving needs 77 
of drug development, formulation engineering and manufacturing processes could hold great 78 
promises on homogeneous drug particles, the creation of new and tailor-made solid dosage 79 
forms, improvements in handling moisture sensitive and electrically charged single drug 80 
particles, and a decrease in the number of excipients and manufacturing process steps. In 81 
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addition to pure drug substances and single particles, ALD coatings could be also applicable for 82 
larger, more complex shaped, porous and heterogeneous substrates, such as tablets. The approach 83 
seems attractive, as ALD coatings are not only continuous, ultra-thin, dense, and smooth, but 84 
also most importantly pinhole-free, very conformal to the substrate, and provide good diffusion 85 
barriers with low gas and moisture permeability (George, 2010). In addition, the thin ALD 86 
coatings can reach and fill the surface of even the deepest and narrowest voids and pores (Ritala 87 
and Leskelä, 2002). Therefore, from the pharmaceutical product design and industry point of 88 
view, ALD would provide a very exciting technology not only for drug particle design but also 89 
as a potential method for tablet coating purposes. 90 
ALD nanoscale films are formed (grown through deposition) utilizing self-limiting chemical 91 
reactions between gaseous precursors chemisorbed on a solid substrate surface. For example, 92 
when depositing metal oxide films, compounds of zinc, aluminum or titanium can be used as the 93 
metal precursors and water as the oxygen precursor. In many cases, the ALD growth starts by 94 
chemisorption of the metal precursor molecules on the hydroxyl groups of the surface. Tablets 95 
should allow the initiation of the nanolayering process of ALD, as they are commonly composed 96 
of multiple organic excipients containing free hydroxyl groups. In tablets, the number of surface 97 
hydroxyl groups required for attachment of molecules can even be created with the small amount 98 
of surface moisture readily existing on tablet surfaces and pores. Moreover, from a possible 99 
tablet coating point of view, the chemical components like zinc, aluminum and titanium oxides 100 
applied by ALD are all established pharmaceutical excipients, and thus their compatibility and 101 
safety profiles are well known. Also, compared to the conventional polymer film coating, ALD 102 
process is very different. The established polymer coating, performed by a fluidized-bed 103 
technique, sets high demands for tablet core strength, and consequently, for tablet formulation 104 
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design. During polymer coating in a fluidized-bed, tablets are exposed to frequent collisions, 105 
high friction, increased moisture and high temperature. Consequently, tablet cores with limited 106 
hardness and mechanical strength are eroded and broken down, especially in the beginning of the 107 
coating process until the uniform film coating is formed through concomitant moisture 108 
evaporation and polymer particle coalescence (Lehmann, 1997; Mehta, 1997). Thin coating by 109 
ALD does not involve such limitations. In flow type ALD reactor, tablet cores are stationary, and 110 
are coated during separate surface saturation (deposition) cycles involving chemical interactions 111 
(Fig. 1). In theory, in ALD involving metal oxides, a cycle of surface saturation takes place 112 
through two reaction steps performed commonly in vacuum at controlled temperature. During 113 
step one (the first half cycle) the metal precursor such as TiCl4 vapor, pulsed to the coating 114 
chamber, is allowed to react with the free hydroxyl groups on the substrate surface. Therefore, in 115 
theory, the chemical pulse saturates the surface with Ti containing groups through molecular 116 
bonds. During step two (the second half cycle) the molecularly bonded structures on the 117 
substrate surface react with the oxygen precursor (water vapor) and form the first nanolayer of 118 
TiO2. Between these steps, a purge of inert gas (N2) is applied in order to remove any excess of 119 
precursor and the reaction by-products. The thickness of the films can be controlled by repeating 120 
the number of reaction cycles to reach the desired coating thickness. Moreover, compared to the 121 
established polymer coating, the ALD process can be completely pre-programmed, and it does 122 
not involve high labor or coating raw material related costs. 123 
To date, no well-documented or established study to evaluate the feasibility of ALD for thin 124 
coating of tablets has been performed. Lehtonen and co-workers (2013) have evaluated ALD on 125 
simple and single material layered tablets, but as pharmaceutical solids traditionally are 126 
heterogeneous and complex substrates, a need for a more thorough study on the applicability of 127 
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ALD on tablets is evident. Moreover, taste and odor masking capacity of ALD has been studied 128 
only on fish oil containing soft gel capsules (Lehtonen et al., 2013). Therefore, we are also 129 
completely lacking of information on the applicability and capacity of such ALD ultrathin 130 
coatings to improve palatability and taste masking associated with tablets. 131 
Here, we therefore introduce our study describing ALD on minitablets composed of multiple 132 
excipients and a bitter tasting model drug. We investigated ALD as a novel technique for thin 133 
coating of minitablets, and for masking the bitter taste of model substance of denatonium 134 
benzoate. Special attention was paid to the effects of the ALD nanolayering process on the 135 
minitablet properties and taste masking efficacy. An established bottom-spray fluidized-bed 136 
coating (with a Wurster column set-up) was used as a reference coating technique. 137 
2. MATERIALS AND METHODS 138 
2.1 Materials 139 
Granules were prepared using denatonium benzoate (Sigma-Aldrich, China) as a model 140 
substance of a bitter tasting active drug ingredient (0.04% m/m). Microcrystalline cellulose 141 
(MCC) (Avicel® PH-102, FMC Corporation, Ireland) (63% m/m) and calcium hydrogen 142 
phosphate dihydrate (Emcompress®, Albright & Wilson, Australia) (30% m/m) were used as 143 
fillers, and hydroxypropyl cellulose (HPC) (Klucel® JXF, Aqualon France SA, France) (3% 144 
m/m) and crospovidone (Kollidon® CL-F, BASF Corporation, Germany) (4% m/m) as a binder 145 
and disintegrant, respectively. Sodium stearyl fumarate (Pruv®, JRS Pharma, Spain) (1% m/m) 146 
was added as a lubricant before tableting.     147 
The synthetic copolymer based on butyl methacrylate, (2-dimethylaminoethyl) methacrylate and 148 
methyl methacrylate (1:2:1) (Eudragit® E PO, Evonik Industries AG, Germany) was used as a 149 
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film forming and taste masking polymer in film coating of minitablets. Lutrol® F127 (poloxamer 150 
407, BASF, Germany) (10% m/m, on dry polymer) and dibutyl sebacate (Fluka Chemie AG, 151 
Germany) (15% m/m, on dry polymer) were used as the dispersing agent and plasticizer, 152 
respectively. Magnesium stearate, Ph.Eur. (donated by Orion Pharma, Finland) was used as an 153 
antitacking agent (35% m/m, on dry polymer). Distilled water was used as a dispersion medium 154 
for film coating. 155 
ALD TiO2 films were grown from titanium tetrachloride (TiCl4) (Sigma-Aldrich, USA) and 156 
deionized water. TiO2 was chosen over zinc and aluminium oxides due to its common use as a 157 
coloring agent in pharmaceutical coating formulations. The TiO2 was considered beneficial also 158 
for taste masking purpose due to its hydrophobic (water insoluble) nature. 159 
Distilled water was used as a test medium for tablet disintegration in vitro. The in vitro 160 
dissolution tests were performed using sodium phosphate buffer (SPB) pH 7.6 (US 161 
Pharmacopoeia) as a testing medium. The SPB was composed of sodium hydroxide (VWR 162 
International S.A.S., France), KH2PO4 (Riedel-de Haën, Germany) and distilled water. The 163 
uniformity of content test of minitablets was also performed with SPB (pH 7.6). 164 
Acetonitrile (ACN) (Sigma-Aldrich Chemie GmbH, Germany) and aqueous 10mM ammonium 165 
acetate pH 4.5 (Sigma-Aldrich Chemie GmbH, Germany) were used as eluents for high 166 
performance liquid chromatography (HPLC) analyses conducted for the dissolution and 167 
uniformity of content tests.  168 
2.2 Design of experiments 169 
Three different number of coating cycles (100, 300 and 500 cycles) resulting different coating 170 
thicknesses were used for the ALD thin coating of minitablets. The numbers of cycles were 171 
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selected based on the results of preliminary experiments on ALD. For the polymer coating of 172 
minitablets, the design of experiments involved four different polymer coating concentrations of 173 
2, 4, 6 and 8 mg/cm2. The levels were selected based on the existing knowledge on the minimum 174 
coating thickness of Eudragit® E (1-2 mg/cm2) effective enough for taste masking (Evonik, 175 
2009). 176 
2.3 Preparation of granules and minitablets 177 
Wet granulations of powder mixtures (400 g) were performed in a Diosna high-shear granulator 178 
(Dierks&Söhne GmbH, Germany) using distilled water as a granulating liquid. The mixing 179 
speeds for impeller and chopper were 600 rpm and 1500 rpm, respectively. The water spraying 180 
rate of 140 g/min was used. MCC, calcium hydrogen phosphate dihydrate, HPC and 181 
crospovidone were first dry mixed for two minutes. Then, the aqueous solution of denatoniun 182 
benzoate was pipetted onto the surface of mixed dry powder bed, and subsequently distilled 183 
water was sprayed while continuously mixing a powder blend. When the total amount of water 184 
(0.45 g/g) was added, granulation was stopped without any kneading phase. The total amount of 185 
water was empirically determined based on the preliminary granulation experiments. 186 
Wet granules were wet-sieved (Quadro Comil, Quadro Engineering, Canada) and tray-dried at 187 
40°C for 2 hours, and subsequently at room temperature (RT) for overnight. Prior to tablet 188 
compression, the dried masses were sieved (Quadro Comil) with a mesh size of 800 μm. 189 
Lubricant (sodium stearyl fumarate) was added and mixed with the granules (Turbula, Willy A. 190 
Bachofen AG, Switzerland) for 5 minutes. The masses intended for minitablet compression were 191 
allowed to equilibrate at RT/60%RH (relative humidity) for at least 12 hours before tableting.  192 
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The granulated masses were tableted at RT/50%RH with a rotary tablet press (Ronchi, Officine 193 
Meccaniche F.lli Ronchi, Italy) and single tip punches of 3 mm in diameter to receive round and 194 
biconvex minitablets with a target weight of 25 mg and denatonium benzoate strength of 10 µg. 195 
Tablets were produced in three separate batches. The average upper and lower punch 196 
compression forces (and relative standard deviations, RSD) for the batches I-III were as follows: 197 
Batch I 1.8 kN (10.3%) / 0.7 kN (27.1%); Batch II 2.0 kN (11.9%) / 1.8 kN (13.8%); and Batch 198 
III 1.7 kN (10.6%) / 1.5 kN (11.6%). 199 
2.4 Polymer film coating of minitablets 200 
The aqueous polymer coating dispersions were prepared by adding emulsifier and plasticizer into 201 
a small portion of distilled water and mixing with a magnetic stirrer. Next, the film-forming 202 
polymer was progressively added into the aforementioned solution and mixed with a magnetic 203 
stirrer for 30 minutes. Magnesium stearate was then homogenously suspended in the remaining 204 
portion of water for 30 minutes with a high-shear mixer (Ultra-Turrax, IKA, Germany). The 205 
magnesium stearate suspension was added to the polymer dispersion, and the mixture was 206 
rapidly homogenized with a high-shear mixer. Finally, the coating suspension was passed 207 
through a 500-μm sieve. The final coating dispersions were continuously mixed for overnight 208 
with a magnetic stirrer prior to film coating process. 209 
Polymer coating of minitablets was performed in a laboratory-scale fluidized-bed apparatus 210 
(Aeromatic AG, Switzerland) equipped with bottom spray-installed Wurster set-up. The height 211 
of the Wurster column was 7.0 cm. The nozzle was a Schlick 970/7-1 pneumatic external mixing 212 
two-fluid nozzle (Düsen-Schlick GmbH, Germany). The coating processor with instrumentation 213 
was connected to a PC and operated via InTouch –software (Wonderware, USA). The coating 214 
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batch size was 100 g. The atomizing air pressure was 1.1 bar and the inlet air volume (air flow 215 
rate) 12.5 l/s. All coatings were performed in an ambient inlet air RH of 22 ± 0.4% measured 216 
with a Vaisala HUMICAP® HMT100 humidity and temperature probe (Vaisala Oyj, Finland). 217 
Before each coating experiment, the coating chamber (made of glass) was preheated with an inlet 218 
air flow rate of 12.5 l/s, inlet air temperature of 40-50°C, and outlet air temperature of 219 
approximately 40°C. The main parameters for nozzle diameter, atomizing air pressure, inlet air 220 
volume, inlet air temperature and spraying rate describing the actual coating process are given in 221 
Table 1. The end-point of a spraying phase was determined as the point where the theoretical 222 
polymer amount of 2, 4, 6 and 8 mg/cm2 was achieved. The end-point of a drying phase was 223 
reached when the difference in RH between the inlet and outlet air was constant. Coated 224 
minitablets were further tray-dried and cured at 40°C for 24 hours. 225 
2.5 ALD coating of minitablets 226 
The ALD was performed in a laboratory-scale flow type ALD reactor (Beneq TFS 200, Finland). 227 
Uncoated minitablets were placed on the bottom of the reactor plate and pretreated in the reactor 228 
at 65°C and at the pressure of 2 mbar for 24 hours prior to deposition to remove the moisture 229 
from the tablets. The thin nanolayers of TiO2 were grown on minitablets from TiCl4 and water at 230 
65°C. Nitrogen (N2) was used as a carrier and purging gas. The TiCl4 and water were evaporated 231 
from the sources at 20°C. The cycle consisted of a 300 ms TiCl4 pulse, 20 s N2 purge, 300 ms 232 
water pulse and 30 s N2 purge. The number of ALD cycles was 100, 300 and 500 corresponding 233 
to approximately 10, 30 and 50 nm film thicknesses measured from the silicon reference sample 234 
processed in the same runs. Using the approximate coating film thickness (10, 30 and 50 nm) and 235 
the density of TiO2 (4.23 g/cm
3), the amount of TiO2 coating was 0.0042 mg/cm
2, 0.0127 236 
mg/cm2 and 0.0212 mg/cm2 corresponding to respective ALD cycles of 100, 300 and 500. After 237 
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the coating, the minitablets were collected from the coating chamber and were stored in carefully 238 
closed glass vials at RT prior to further analyses. 239 
2.6 Characterization of minitablets 240 
The surface morphology of uncoated and coated minitablets containing denatonium benzoate 241 
was studied using a scanning electron microscope (SEM) (FEI Quanta FEG250, FEI Inc., USA) 242 
at the Electron Microscope Unit, Institute of Biotechnology, Helsinki, Finland. Dry platinum-243 
coated samples were scanned using a voltage of 10 kV. The surface morphology and surface 244 
content analysis for uncoated and TiO2 coated minitablets (500 cycles) were further determined 245 
by field emission scanning electron microscope with energy dispersive spectroscopy (SEM-EDS) 246 
(Hitachi S-4800 equipped with Oxford INCA 350) at the Department of Chemistry, Helsinki, 247 
Finland. The measurements were performed using the voltage of 20 kV. Minitablet samples were 248 
coated with carbon prior to the measurements.  249 
The height of minitablets was measured with a Sony digital micrometer (Sony Digital Indicator 250 
U30-F, Sony, Japan) (n=10). The uniformity of mass and uniformity of content tests were 251 
performed according to Ph. Eur. (the tests described in the chapters 2.9.5 and 2.9.6, respectively). 252 
The dissolution of denatonium benzoate minitablets was determined using a modified Ph.Eur.  253 
(2.9.3) basket method and apparatus A (Erweka DT6, Erweka GmbH, Germany) (n=4). The 254 
dissolution medium was 40 ml of SPB (pH 7.6) at 37 - 38°C. The basket rotation speed was 50 255 
rpm. The samples were collected manually at time periods of 0 and 15 s, and then, after every 30 256 
seconds until the end-point of 6 minutes 15 s. The dissolution sample size for denatonium 257 
benzoate containing minitablets was 250 µl. Prior to HPLC analysis, the samples were 258 
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centrifuged (13,200 rpm/5 min) and pipetted into HPLC sampling vials. HPLC analyses were 259 
performed within 24 hours after dissolution testing. 260 
The disintegration tests of uncoated and coated minitablets were performed using a Sotax DT3 261 
tablet disintegration apparatus (Sotax AG, Switzerland). The method was slightly modified for 262 
small minitablets from the standard Ph.Eur. tablet disintegration method (2.9.1): the bottom of 263 
each testing cylinder was covered with a stainless steel mesh (with an average mesh size 0.2 264 
mm) to prevent a small tablet dropping down to the bottom of a test glass beaker. 265 
The tablet breaking force (tablet hardness) was determined using a Schleuniger-2E tablet 266 
hardness tester (Dr. K. Schleuniger & Co., Switzerland) with a slight modification compared to 267 
the Ph.Eur. method (2.9.8). Instead of determining the load required to crush a tablet 268 
diametrically (when placing tablets diametrically onto their flat side between the jaws), tablets 269 
were placed diametrically on their edge (belt) between the jaws. This was due to the occasional 270 
non-detectability of the load needed to crush the minitablet placed diametrically onto their flat 271 
side. 272 
2.7 HPLC assays 273 
For the uniformity of content and dissolution tests, the samples were analyzed using an Agilent 274 
1100 series HPLC system (Agilent Technologies, USA) equipped with an UV-Vis detector. The 275 
reverse-phase column Zorbax Eclipse Plus C18 (100x4.6 mm, 3.5 μm) (Agilent Technologies, 276 
USA) was utilized in the analyses.  277 
The flow rate of eluent mixture of ammonium acetate (10 mM, pH 4.5):ACN was 1 ml/min. 278 
Denatonium benzoate was detected at wavelength 210 nm at 25°C. For uniformity of content 279 
test, the corresponding ratio of the eluents and the retention time of denatonium benzoate was 280 
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55:45 and 1.8 min (for the uncoated and the polymer coated minitablets), and 60:40 and 2.4 min 281 
(for the uncoated and the TiO2 coated minitablets). For dissolution testing of uncoated and both 282 
polymer and TiO2 coated minitablets, the ratio of the eluents was 60:40, and the retention time of 283 
denatonium benzoate was 2.4 min.  284 
2.8 Statistical method of calculation 285 
The Student´s t-test (two-tailed distribution, two-sample unequal variance) was used for the 286 
calculation of statistical differences between uncoated and coated tablets, these in the results of 287 
tablet dissolution, uniformity of tablet mass and denatonium benzoate content, tablet 288 
disintegration rate, breaking force and height. Difference between uncoated and coated tablets 289 
was considered statistically significant with p<0.05. 290 
3. RESULTS 291 
3.1 Content and dimensions of minitablets 292 
Table 2 shows the weight, active ingredient content, disintegration time, breaking force and 293 
height of uncoated and coated tablets. For TiO2 coated minitablets, no statistically significant 294 
(p<0.05) change in the tablet height between uncoated tablets and different coatings of 100, 300 295 
or 500 cycles was revealed, though the average tablet height of uncoated tablets was slightly 296 
higher than that of coated minitablets. As expected, similarly to tablet height, no changes in the 297 
weight of TiO2 coated minitablets or denatonium benzoate content were revealed. 298 
Compared to uncoated tablets, a slight decrease in the denatonium benzoate content was 299 
observed in polymer film coated tablets, the difference being statistically significant with 300 
polymer amounts of 6 and 8 mg/cm2 (Table 2). In comparison to uncoated tablets, film coated 301 
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tablets exhibited also an increase in the tablet height and weight, particularly with polymer 302 
amounts of 4, 6 and 8 mg/cm2 (tablet height) and with polymer amounts of 2, 6 and 8 mg/cm2 303 
(tablet weight). The difference between uncoated and polymer coated tablets seemed gradual and 304 
in accordance with increased polymer amount. The increase in tablet height with coating of 305 
polymer amounts of 2 and 4 mg/cm2 was lower than with polymer amounts 6 and 8 mg/cm2. The 306 
highest increase in tablet height and weight was observed with polymer amount of 8 mg/cm2. 307 
Tablet height remained relatively unchanged with polymer amount of 2 mg/cm2 when compared 308 
to uncoated tablets. However, the average weight of minitablets with coating of 2 mg/cm2 309 
decreased in comparison to uncoated minitablets.  310 
3.2 Minitablet hardness 311 
The TiO2 coating significantly (p<0.05) decreased the breaking force (hardness) of minitablets in 312 
comparison to uncoated minitablets (Table 2). No difference in the breaking force of minitablets 313 
between different TiO2 thicknesses (100, 300 and 500 cycles) was revealed.  314 
Surprisingly, the breaking force of polymer film coated tablets was also lower than that of 315 
uncoated minitablets. No changes in the breaking force were seen between the minitablets coated 316 
with polymer concentration of 2 and 4 mg/cm2, and between the minitablets coated with polymer 317 
concentration of 6 and 8 mg/cm2. 318 
3.3 Disintegration in vitro 319 
The disintegration times of uncoated, TiO2 coated, and polymer film coated minitablets are 320 
presented in Table 2. Surprisingly, the disintegration time of TiO2 coated minitablets was clearly 321 
shorter (p<0.05) than that obtained with uncoated minitablets. No clear differences in the 322 
disintegration times between ALD coated tablets (100, 300 and 500 cycles) were revealed as the 323 
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disintegration tendency described by the average disintegration time was only slightly decreasing 324 
over coating cycles. 325 
Surprisingly, the disintegration time of minitablets coated with polymer concentrations of 2 and 326 
4 mg/cm2 was shorter in comparison to that of uncoated minitablets. However, minitablets 327 
coated with polymer concentration of 4 mg/cm2 disintegrated more slowly than minitablets 328 
coated with 2 mg/cm2 polymer concentration. In addition, the disintegration time of minitablets 329 
coated with polymer concentration of 6 mg/cm2 was shorter than that of minitablets coated with 330 
higher amount (8mg/cm2) of polymer, but compared with uncoated tablets, the difference with 331 
polymer amount of 6 mg/cm2 was not statistically significant. As expected, the disintegration of 332 
minitablets containing polymer concentration of 8 mg/cm2 was slower than that of uncoated or 333 
other polymer coated tablets of the study. In addition, the minitablets coated with higher polymer 334 
concentration of 8 mg/cm2 exhibited a clear lag-time prior to disintegration which was not 335 
observed with the TiO2 coated minitablets. 336 
3.4 Dissolution in vitro 337 
The dissolution profiles of uncoated, ALD coated (TiO2) and polymer film coated minitablets are 338 
shown in Fig. 2. With both uncoated and ALD coated minitablets (100, 300 and 500 cycles), the 339 
lag-time for denatonium benzoate release was very short (less than 45 seconds). With polymer 340 
film coated minitablets, denatonium benzoate release was detected at 45 s (2, 4 and 6 mg/cm2) 341 
and at 1 min 15 s (8 mg/cm2).  342 
At 45 seconds, the highest amount of released denatonium benzoate was detected for minitablets 343 
containing 2 mg/cm2 and 4 mg/cm2 of coating polymer, while no difference in the released 344 
amount of denatonium benzoate was revealed between uncoated and polymer film coated (6 345 
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mg/cm2) minitablets. The polymer film coating of minitablets (2, 4 and 6 mg/cm2) increased the 346 
release rate of denatonium benzoate compared to that obtained with uncoated minitablets. 347 
However, when the highest amount of coating polymer (8 mg/cm2) was used, the minitablets 348 
exhibited a clear delay in the release rate of denatonium benzoate.  349 
TiO2 ALD coating on minitablets had only a small effect on the release rate and profile of 350 
denatonium benzoate. The slowest release of denatonium benzoate was revealed for 500 cycles 351 
ALD TiO2 coated minitablets. Application of 100 and 300 cycles in the TiO2 ALD coating of 352 
minitablets exhibited only a slight delay in the release rate of denatonium benzoate compared to 353 
that obtained with uncoated minitablets. 354 
3.5 SEM and EDS 355 
The SEM images defining the internal structure and surface morphology of uncoated and coated 356 
minitablets are shown in Fig. 3. The SEM-EDS linescans of TiO2 ALD coated minitablets (500 357 
cycles) are presented in Fig. 4 (intact minitablet) and Fig. 5 (the cross-section of the minitablet). 358 
The surface of uncoated minitablet (Fig. 3A) was relatively smooth with dark and white areas, 359 
and application of TiO2 ALD coating had virtually no effect on the surface morphology of  360 
minitablets (100 cycles in Fig. 3B, 300 cycles in Fig. 3C, and 500 cycles in Fig. 3D). The surface 361 
of polymer film coated tablet (2 mg/cm2 in Fig. 3E) revealed rough eroded holes on an uneven 362 
tablet surface. Smoother and more even minitablet surfaces were obtained with higher coating 363 
polymer concentrations (4 mg/cm2 in Fig. 3F, 6 mg/cm2 in Fig. 3G, and 8 mg/cm2 in Fig. 3H).  364 
The SEM-EDS linescan of the TiO2 ALD coated tablet surface revealed the presence of titanium 365 
and chlorine on the surface of minitablets (Fig. 4). Moreover, the intensity of the titanium signal 366 
seemed to be in accordance with the intensities of elements of calcium and phosphorous (arrows 367 
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in Fig. 4 for titanium). With the cut ALD coated minitablet, the intensity of the titanium signal 368 
was verified to be exceptionally high on the minitablet surface but decreased rapidly when 369 
moving towards the minitablet core (Fig. 5). The penetration of Ti into the structure of the tablet 370 
was reaching an approximate depth of 0.2 mm. No titanium was present at the surface of 371 
uncoated minitablet (data not shown). 372 
4. DISCUSSION 373 
4.1 Effect of coating method on the properties of minitablets 374 
It is well known that the tablet cores in a conventional fluidized-bed polymer coating process are 375 
exposed to a long-term attrition (friction) and collisions resulting in the erosion (even breakage) 376 
of tablets during processing. However, the ALD thin coating of tablets with TiO2 in flow type 377 
ALD reactor is a much more gentle procedure as the tablets are stationary during coating and 378 
thus, are not susceptible to kinetical attrition or collisions similar in fluidized-bed. Thus, no 379 
statistically significant differences between uncoated and ALD-coated tablets were revealed for 380 
tablet integrity, weight, dimensions, or active drug content. 381 
Surprisingly, however, the breaking force (hardness) and disintegration time of minitablets 382 
decreased after ALD coating. This was confusing, especially as in the literature, the ALD coated 383 
3-layer tablets have been reported to comply with the specifications for hardness and 384 
disintegration time of such dosage forms (Lehtonen et al., 2013). Thus, by contrast to a decrease 385 
in the minitablet strength and disintegration, a delay was our more likely expectation, 386 
particularly as in theory, the chosen minitablet formulation was thought to support the formation 387 
of even, pinhole-free and moisture protective TiO2 ALD nanolayers. Moreover, in the present 388 
study, the experimental composition of minitablet core was considered ideal for ALD thin 389 
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coating, since the presence of the free hydroxyl groups on the surface of MCC in addition to the 390 
tablet surface moisture were expected to provide excellent binding sites for TiCl4. This should 391 
foster also the formation of homogeneous TiO2 nanolayers on tablet surfaces, voids and crevices, 392 
thus reducing the core ability to interact with its surroundings. Moreover, the low deposition 393 
temperature of 65°C used in the present study was not harmful for the tablet core. In the 394 
literature, TiO2 ALD nanolayering of tablets using TiCl4-water chemistry has been successfully 395 
conducted at temperatures even lower than 65°C (Lehtonen et al., 2013). The decrease in 396 
hardness and disintegration time of minitablets after ALD thin coating can be explained by the 397 
fact that pharmaceutical tablets are heterogeneous and porous solid systems, unlike to the 398 
substrates traditionally used in ALD thin coating. Moreover, the real ALD film growth 399 
mechanism may not be as simple as the theory outlines. 400 
A short interaction between moisture and heterogeneous tablet core components (such as the 401 
disintegrant crospovidone or MCC) can cause the microerosion of tablets during an ALD thin 402 
coating processing. It is evident that this also induces the creation of new pores, new open intact 403 
tablet surfaces, and even new complicated pore networks to the tablet structure. Moreover, the 404 
risk for microerosion can increase (especially at low temperatures) because of the liberation of 405 
the reaction side product of hydrochloric acid gas, due to TiCl4-water chemistry, adsorbing onto 406 
the TiO2 surface (Ritala et al., 1993). As microerosion enlarges, the active surface area of tablets 407 
requiring coating also becomes larger. This means that during deposition the exposed new 408 
surfaces and pore networks are not likely to be adequately covered by TiO2 nanolayers, simply 409 
due to insufficient amount of coating precursor. Thus, microerosion could reduce the layer 410 
moisture protecting capability and accelerate the tablet disintegration rate, as well as decrease the 411 
tablet hardness. Moreover, in theory, the TiO2 is covalently bonded to the hydroxyl-covered 412 
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substrate surface. This could indicate the formation of a completely new chemical component 413 
with characteristics totally different from those of the original substance. Also, the variation in 414 
the configuration and the level of the hydroxyl-grouped surfaces may complicate the film growth 415 
(Ritala et al., 1993). It is evident that areas with uneven and variable level of hydroxyl groups 416 
lead to uneven TiO2 layers. Furthermore, the amphoteric chemical behavior of TiO2 surface due 417 
to differently orientated and bonded hydroxyl groups on the TiO2 surface (Parfitt, 1976) can lead 418 
to additional reactions other than with TiCl4. Low deposition temperatures used in the TiO2 ALD 419 
thin coating can also induce the formation of chemical impurities (residual ions), such as 420 
chlorine in ALD thin films originating from TiCl4 precursor ligands (Ritala et al., 1993; Jõgi et 421 
al., 2006), and may therefore change the film properties. In addition, at this growth temperature 422 
ALD TiO2 thin films are in fact amorphous and may thus have increased intensity for moisture 423 
related interactions. 424 
The success of TiO2 ALD coating is therefore very much dependent on the tablet core 425 
composition, structure and properties. With the present minitablets, phenomena occurring on the 426 
heterogeneous tablet surface are hence strongly emphasized. Lehtonen and co-workers (2013) 427 
investigated the ALD thin coatings applied to the tablets composed of three-layered 428 
pharmaceutical solids containing layers of probiotics and vitamin C. Pharmaceutical tablets are 429 
commonly compressed from heterogeneous mixtures. Due to such complex compositions, the 430 
coatings applied to the outer surface of tablet cores are exposed to multiple different 431 
components, which all have characteristic porosity and interaction capabilities, e.g. with 432 
moisture or chemicals. Consequently, the formation of even and pinhole-free TiO2 ALD 433 
nanolayers is greatly affected by the chemical composition of the tablet surface (especially, the 434 
excipients rich on hydroxyl groups play a key role), and most likely also by surface moisture. In 435 
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other words, the formation and growth of TiO2 thin films is fostered by the surfaces exhibiting 436 
very high hydroxyl group density. In addition, the pore density, size and tortuosity of excipients 437 
can play a crucial role affecting TiO2 ALD thin films. Depending on the physicochemical 438 
characteristics, the active outer surface area of tablet excipients can be very different due to 439 
interaction with moisture. Consequently, deep voids or complex pore structures can result in 440 
inadequate TiO2 ALD nanolayer formation and growth. Moreover, the formation of intact TiO2 441 
ALD coating in tablet pores is most likely to be fostered by the presence of high hydroxyl group 442 
density. With the present minitablets, it is evident that excipients and/or denatonium benzoate 443 
interact with titanium to different extent and mechanism, thus affecting the formation of 444 
nanolayers. Therefore, the reason for the unexpected decrease in the hardness and disintegration 445 
time of coated minitablets is most likely the heterogeneity and physicochemical diversity of 446 
chemical components in the tablet surface. 447 
ALD thin coating has a number of advantages compared to a traditional fluidized-bed film 448 
coating method. The TiO2 ALD nanolayering is a gentle procedure in a flow type reactor without 449 
any actual collision related impact on tablets. On the contrary, the traditional fluidized-bed 450 
coating requires adequate mechanical strength of tablet cores, and appropriate and well-designed 451 
tablet compositions. In a fluidized-bed coating process, tablet breakage takes place readily due to 452 
a long-term collision and abrasion during fluidization, and due to the elevated temperature and 453 
humidity conditions during polymer dispersion spraying and drying. Moreover, particles 454 
detached from tablet cores can disturb the formation of even polymer coating and lead to a great 455 
variation in an active ingredient content, disintegration and dissolution of tablets. It is also well-456 
known that traditional polymer film coating can lead to a significant increase in tablet weights 457 
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and delay in disintegration times, especially if thick polymer coatings involving high amounts of 458 
polymer are used.  459 
In our study, fluidized-bed polymer film-coated tablets exhibited a clear decrease in hardness 460 
(breaking force), tablet weight and denatonium benzoate content compared to the corresponding 461 
uncoated tablets, all mostly related to tablet erosion and breakage during film coating process. 462 
The possibility for tablet breakage was expected to be avoided with the inclusion of MCC as a 463 
main component in the tablet core formulation. MCC deforms plastically under compression and 464 
maximizes the area of inter-particle hydrogen bonding, thus increasing tablet mechanical 465 
strength and hardness (Bolhuis and Lerk, 1973). Consequently, no friability test was performed 466 
for the MCC containing minitablet cores, and also because the tablet friction during the strong 467 
fluidization in the actual fluidized-bed apparatus was considered to provide a more accurate 468 
result for tablet friability. MCC can also entrap and hold significant amounts of moisture inside 469 
its structure (Zografi and Kontny, 1986), thus making it an excipient of choice for the moisture-470 
sensitive ingredients in tablets. Its moisture related interactions during processing and drying are 471 
also well-documented (Luukkonen, 2001; Luukkonen et al., 2001; Kleinebudde, 1994). 472 
In fluidized-bed coating, several process-related conditions (e.g. high humidity, agitation and 473 
elevated temperatures during spraying and drying) can affect the final polymer film coated 474 
tablets. Using aqueous polymer coating dispersions, the process-induced changes (interactions) 475 
are naturally more evident if the tablet cores are composed of amorphous and/or moisture 476 
sensitive excipients, e.g. binders (HPC) or disintegrants (crospovidone) (Joshi and Petereit, 477 
2013). These changes are also greatly dependent on the duration (time) of a fluidized-bed 478 
process. In our study, the most significant process-induced changes were resulted by the decrease 479 
of the hardness of minitablets. 480 
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We found that the minitablet cores used in the fluidized-bed polymer coating experiments did not 481 
completely withstand the process conditions (agitation, high humidity and elevated temperature). 482 
This was obviously partly due to the interaction of MCC with moisture, thus leading to a notable 483 
decrease in the mechanical strength (hardness) of tablets. This finding is also in good agreement 484 
with that reported in the literature (Westermarck et al., 1999). Moreover, the moisture-induced 485 
softening and erosion of tablet cores are most likely fostered with the presence of moisture-486 
sensitive HPC and crospovidone in the tablet formulation. The deteriorating influence of 487 
moisture and agitation continues until the uniform and intact film coating is formed around 488 
tablets. Deterioration of polymer film-coated tablets can continue even after a coating process, if 489 
moisture is entrapped inside the tablet core and polymer film. 490 
To avoid tablet deterioration related problems with moisture-sensitive tablet formulations, 491 
spraying of polymer dispersion in fluidized-bed coating could be started with a small amount of 492 
dispersion followed by an immediate drying phase. This kind of spraying protocol is expected to 493 
enhance the initial film formation, thus protecting tablet cores from future moisture interactions. 494 
In the fluidized-bed film coating of minitablets, it is also important to control and optimize the 495 
spraying properties of dispersion such as droplet size in order to avoid over-wetting and 496 
subsequent softening of tablet cores. Compared to large-sized tablets, adequate coating of 497 
minitablets containing swellable excipients in particular requires higher amounts of coating 498 
polymer due to the larger outer surface area of such minitablets (Mehta, 1997). This is even more 499 
important with taste masking film coatings where the applicability and efficacy of coating is 500 
dependent of film thickness and intactness. One option to overcome the challenge associated 501 
with the larger outer surface area of minitablets is to prolong contact time of tablet cores with the 502 
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coating polymer dispersion, e.g. by modifying a Wurster column set-up or by increasing a 503 
coating process time. However, such changes will impact also the other coating parameters. 504 
4.2 Taste masking efficacy of minitablets 505 
Sensing the taste requires the initial interaction of the tablet with moisture (saliva), and 506 
subsequent tablet disintegration and dissolution of tastant in the oral cavity. The sensory 507 
information from the tongue is then instantly transmitted via neural pathways to the brain to be 508 
interpreted as taste perception (Thombre, 2004). The requirement of saliva solubility makes the 509 
taste a chemical sense. Normally, the physiological pH of human saliva is neutral varying from 510 
pH 6 to pH 7.5 (Tenovuo, 1995). The diet can greatly affect the pH of saliva. Therefore, the 511 
typical pH of saliva in herbivores and omnivores is more alkaline than the saliva pH of 512 
carnivores. 513 
For the evaluation of minitablet dissolution and bitter taste masking efficacy in vitro, we used an 514 
aqueous buffer solution pH 7.6 representing the average pH for the saliva. The expected 515 
residence time of tablets in the mouth was also taken into account in a study protocol. In our 516 
study, a mouth residence time longer than 45 seconds without detected bitter tasting denatonium 517 
benzoate was required for effective minitablet taste masking, as on average, the time period of a 518 
solid dosage form to remain in the mouth is relatively short ranging from a few seconds to 30-60 519 
seconds (Joshi and Petereit, 2013). In this study, the modified disintegration and dissolution tests 520 
of minitablets in vitro were used to indirectly show the taste masking efficacy of the coated 521 
tablets. With better mimicking of the soft tissue function and conditions in the mouth and 522 
gastrointestinal system, the more gently proceeding tablet dissolution test with results on 523 
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detected denatonium benzoate release were emphasized when used as a tool for the rapid taste 524 
masking efficacy evaluation purposes of the coated minitablets of the study. 525 
The in vitro dissolution results of TiO2 ALD coated minitablets were in accordance with the in 526 
vitro disintegration times of the respective nanolayered minitablets (Fig. 2). The early 527 
denatonium benzoate release from both uncoated and TiO2 ALD coated minitablets was 528 
observed at 45 s. This suggests that the coating thickness of the present ALD nanolayered 529 
minitablets (i.e., the coating cycles of 100, 300 and 500) is not sufficient for the effective taste 530 
masking. The present finding is rather surprising since the multiple TiO2 nanolayers were 531 
expected to act as effective barriers to prevent water and oxygen penetration, and thus delay the 532 
onset of denatonium benzoate release, and moreover, as Lehtonen and co-workers (2013) 533 
reported about the delay in the onset of drug release of TiO2 ALD layered vitamin C tablets as 534 
well as the taste and smell masking of ALD coated fish oil soft gelatin capsules. In our study, 535 
only negligible delay in the dissolution of denatonium benzoate from TiO2 coated minitablets 536 
was observed, this regarding minitablets coated with 500 coating cycles. Furthermore, no 537 
statistical significant difference (p>0.05) was found between the early-stage dissolution (within 538 
45 s – 1 min 15 s) of TiO2 ALD layered minitablets compared to uncoated minitablets.  539 
We found that the minitablets coated with a polymer amount of 8 mg/cm2 are evidently 540 
applicable for the bitter taste masking of denatonium benzoate. The present fluidized-bed coated 541 
minitablets exhibited the most extensive delay in the onset of disintegration and dissolution in 542 
vitro (Fig. 2 and Table 2). However, it should be emphasized that the dissolution and mechanical 543 
properties (softening) of these polymer film coated minitablets are greatly dependent on the 544 
fluidized-bed coating conditions. The ALD thin coating method has some advantages over 545 
fluidized-bed coating conditions. The ALD nanolayering is a simple and rapid method, and 546 
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especially applicable in case of moisture sensitive tablet formulations since tablet cores are not 547 
exposed to high humidity conditions similar to those in fluidized-bed coating. Consequently, 548 
ALD nanolayering should not affect the physicochemical and pharmaceutical properties of 549 
tablets. Our results suggest also that the adequate taste masking efficacy of minitablets could be 550 
achieved by increasing the number of coating cycles in the TiO2 ALD nanolayering, as the 551 
release of bitter tasting denatonium benzoate was, though only slightly, delayed from minitablets 552 
coated with 500 coating cycles. Attention should also be put onto the time required for the 553 
precursor pulse, as the unexpected dissolution of TiO2 coated minitablets could be also explained 554 
by the pulse of 300 ms being possibly inadequate for precursors to penetrate into the tablet pores. 555 
In addition, the coating materials other than TiO2 or the multilayer ALD coatings could also open 556 
new alternatives to single ALD thin coatings for taste masking applications. For example, Al2O3 557 
ALD thin coated tablets have been shown to exhibit faster drug release in water in comparison to 558 
TiO2 ALD coated tablets (Lehtonen et al., 2013). The use of an ALD coating system (reactor) 559 
other than the flow type one could also provide improvements in taste masking efficiency. 560 
Carlsson and co-workers (2016) reported the existence of holes in the ALD coated nanoparticles 561 
due to the contact points with other nanoparticles during deposition. In theory, this could be also 562 
possible with the present TiO2 ALD thin-coated minitablets, since the exposure of stationary 563 
tablet(s) to ALD could lead to disruptions in thin coatings due to the direct contact of the tablet 564 
lower surface with an ALD tray. The probability for the formation of uncoated contact points in 565 
minitablets, however, is minimal, since the tablets are slightly vibrating in the semifluid state 566 
during the flow of ALD coating. Therefore, the major reason for the defects of TiO2 ALD thin 567 
coating (and obviously for a limited taste masking efficacy of minitablets) is the heterogeneous 568 
structure of the tablet surface. It is evident that the surface moisture is adequate for ALD and for 569 
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the formation of even TiO2 nanolayers, but the affinity of some tablet excipients varies a lot and 570 
this can prevent the formation of homogeneous and continuous TiO2 nanolayers. 571 
4.3 Surface morphology and content analysis 572 
The surface properties of fluidized-bed film coated minitablets were dependent on the amount of 573 
coating polymer used. The minitablets coated with the lowest polymer amount of 2 mg/cm2 574 
exhibited a large variation in film coating appearance (quality) due to erosion and tablet breakage 575 
(Fig. 3E). The tablets coated with the highest polymer amount of 8 mg/cm2 had an intact and 576 
smooth surface (Fig. 3H). The actual coating thickness of polymer coated tablets ranged from 577 
some tenths of micrometers (2 mg/cm2) to a few hundred micrometers (8 mg/cm2). Such great 578 
variation in coating thicknesses (and intactness) explains also the changes in physical and 579 
pharmaceutical properties of minitablets coated with different amounts of polymer. 580 
Since SEM did not permit the nanometer-scale analysis of the ALD nanolayered minitablets, the 581 
surface of an uncoated and a TiO2 coated (500 cycles) minitablet was analyzed also with SEM-582 
EDS. This analysis (elemental mapping) was primarily carried out to explain the accelerated 583 
disintegration and dissolution behavior of ALD thin-coated minitablets. The presence of Ti 584 
signal on the porous ALD coated minitablet surface can be considered as an important 585 
verification on the successful nanolayer formation onto the surface of minitablets. In accordance 586 
to the theory on hermetic ALD layers on porous minitablets, the SEM-EDS results suggested that 587 
the TiO2 layer was integral and indeed entirely covering the various areas over the linescan on 588 
the minitablet surface leaving no disrupted areas in the coating. Moreover, in agreement with our 589 
theory of ALD thin coating on porous tablets, the TiO2 precursors seem to diffuse into the voids 590 
and pores of minitablets with the estimated diffusion length of approximately 100-200 μm. This 591 
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finding supports the view that the ALD thin coating of minitablets can be successfully 592 
performed. The major limitation of the presented coated substrates, however, was that they did 593 
not permit us to analyze the interface between the minitablet core and nanolayer, and thus to 594 
determine the actual thickness of titanium coating. Lehtonen and co-workers (2013) used SEM to 595 
measure a nanometer scale Al2O3 (10 nm) + TiO2 (10 nm) layer thickness of fish oil containing 596 
soft gel gelatin capsules. In our study, however, the analysis of the interface of tablet core and 597 
nanolayers, and coating thickness are much more challenging due to the porous structure of 598 
tablet surface compared to that of soft gelatin capsule. Nevertheless, this issue could be 599 
overcome by the verification of integral titanium layer on minitablets combined with the known 600 
theoretical nanocoating thickness. 601 
In addition to titanium, traces of chlorine were also present on TiO2 ALD coated minitablet 602 
surface. This is obviously due to a porous substrate and low ALD coating temperature of 65°C 603 
which is known to leave residuals of incompletely reacted TiCl4 on surfaces (Ritala et al., 1993). 604 
The residuals present could be minimized by increasing the ALD coating temperature up to and 605 
even over 200°C (Ritala et al., 1993). Many active pharmaceutical substances and excipients, 606 
however, are thermally sensitive, which limits the use of very high handling temperatures during 607 
ALD thin coating. Further studies will be needed on the formation and role of precursor residuals 608 
(including safety and toxicity) in ALD nanolayers. 609 
The SEM-EDS morphological and elemental analysis revealed that the surface of uncoated 610 
minitablets is porous and heterogeneous due to the multiple excipients used for formulating the 611 
tablet cores. The surface of uncoated minitablets (cores) was covered with the grey-white and 612 
dark areas (spots), which were still clearly visible in TiO2 ALD coated tablets. The bright areas 613 
revealed a more intense signal for phosphorous and calcium over dark areas. The presence of 614 
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phosphorous and calcium refers to the calcium hydrogen phosphate dihydrate used as an 615 
excipient in the minitablet composition. Surprisingly, the behavior of phosphorous and calcium 616 
seemed to be followed by an increase in the manifestation for titanium. The difference in 617 
titanium intensity between white and dark areas was found to be notable and in contrast to other 618 
surface elements. The intensity of titanium was clearly the highest in the white surface areas 619 
together with phosphorous and calcium. 620 
The present finding is considered as significant. The high intensity of titanium signals indicates 621 
that certain pharmaceutical excipients (such as in our study calcium hydrogen phosphate 622 
dihydrate) can be coated (nanolayered) with TiO2 more easily than others. The differences in the 623 
intensity of titanium signals can also indicate the uneven formation of nanolayers on the 624 
heterogeneous surface of minitablets, thus resulting in the limited moisture protection and 625 
changes of the performance of ALD coated minitablets. However, the formation of uneven 626 
nanolayers, can be argued since titanium was also detected in the surface pores of the minitablet 627 
cores, and may therefore not be seen there at the equal levels found in the calcium and 628 
phosphorous rich surfaces. Further studies will be needed on using TiO2 nanolayers with both 629 
active pharmaceutical substances and excipients. 630 
5. CONCLUSIONS 631 
ALD provides a simple and rapid method for the ultrathin coating (nanolayering) of minitablets. 632 
It is evident that the level of agitation and collision forces between tablets in ALD are minor 633 
compared to polymer coating in a fluidized-bed, not to mention that the method is relatively 634 
simple compared to the conventional and challenging polymer film coating process. The ALD 635 
thin coating method has both advantages and limitations over traditional film coating methods. 636 
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The ALD thin coating is a rapid process since no spraying and drying steps are needed. 637 
However, the unexpected changes in the TiO2 ALD coated minitablet mechanical properties seen 638 
as an accelerated tablet disintegration rate and decreased tablet hardness may challenge its 639 
feasibility in the coating of heterogeneous substrates composed of substances with different 640 
chemical characteristics and reaction ability, until a thorough understanding on possible 641 
phenomena taking place on tablet surface and within used diverse and physicochemically 642 
variable excipients during ALD process is established.  Therefore, the major challenges of ALD 643 
thin coating are related to the sufficient taste masking capacity and interactions of 644 
coating/layering material (TiO2) with the excipients used in the tablet core. More research is 645 
needed to clarify the potential of ALD in tablet coating applications. For example, coating 646 
materials other than TiO2, the effects of the number of coating cycles and the length of the 647 
precursor pulses on the taste masking are suggested for further study.  648 
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Captions to illustrations: 713 
Fig. 1. The theoretical formation of TiO2 nanolayers via the chemical reaction between water and 714 
TiCl4 in atomic layer deposition (ALD) thin-coating process. In ALD involving metal oxides, a 715 
cycle of surface saturation takes place through two reaction steps performed commonly in 716 
vacuum at controlled temperature. During step one (the first half cycle) the metal precursor such 717 
as TiCl4 vapor, pulsed to the coating chamber, is allowed to react with the free hydroxyl groups 718 
on the substrate surface. The chemical pulse therefore saturates the surface with Ti containing 719 
groups through molecular bonds. During step two (the second half cycle) the molecularly bonded 720 
structures on the substrate surface react with the oxygen precursor (water vapor) and form the 721 
first nanolayer of TiO2. Between the steps, a purge of inert gas (N2) is applied to the chamber to 722 
remove the possible excess of precursor and reaction by-products. The film thickness is 723 
controlled by repeating the number of reaction cycles to reach the desired coating. 724 
Fig. 2. Dissolution profiles of uncoated minitablets, TiO2 ALD (100, 300 and 500 cycles) thin-725 
coated and fluidized-bed polymer film coated (2, 4, 6 and 8 mg/cm2 of polymer) minitablets 726 
(n=4). The dissolution curves describe the cumulative release of denatonium benzoate from 727 
minitablets. 728 
Fig. 3. Scanning electron microscopy (SEM) images on uncoated minitablet (Fig. 3A), TIO2 729 
ALD thin-coated minitablets (100, 300 and 500 cycles; Fig. 3B-D, respectively) and fluidized-730 
bed polymer film coated minitablets (2, 4, 6 and 8 mg/cm2; Fig. 3E-H, respectively).  731 
Fig. 4. Scanning electron microscopy-energy dispersive spectroscopy (SEM-EDS) image on the 732 
intact TiO2 ALD thin-coated minitablet (500 cycles). Arrows indicate the presence of titanium on 733 
the ALD thin-coated minitablet surface followed by signals on calcium and phosphorous.  734 
Fig. 5. SEM-EDS image on the cross-section of TiO2 ALD thin-coated minitablet (500 cycles). 735 
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Table 1. Used parameters for minitablet polymer coating. 736 
Parameter Value 
Nozzle diameter 0.5 mm 
Atomizing air pressure 1.1 bar 
Inlet air volume 12.5 l/s 
Inlet air temperature 40-50°C 
Spraying rate 2.2 g/min 
  737 
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Table 2. Results of the tests performed on both uncoated, and for TiO2 and EPO coated 738 
minitablets of the study. Statistically significant (p<0.05) difference between uncoated and 739 
coated tablet is marked in bold. 740 
Tablet Uniformity  
of mass 
Average ± SD  
 
(mg) 
 
Uniformity  
of content 
Average ± SD 
 
(mg) 
Disintegration 
rate 
Average ± SD 
 
(s) 
Tablet 
breaking force  
Average ± SD  
 
(N) 
Tablet 
height 
Average ± SD 
 
(mm) 
      
Batch I 
Uncoated 
23.0 ± 0.4 
 
8.6 ± 0.4 
 
48 ± 3 50 ± 4 2.42 ± 0.02 
 
TiO2 coated, 
100 cycles 
 
22.7 ± 0.3 
 
 
8.3 ± 0.4 
  
 
23 ± 2 
  
 
45 ± 2 
 
 
2.41 ± 0.03 
 
TiO2 coated, 
300 cycles 
 
22.8 ± 0.4 
 
 
8.5 ± 0.2 
 
 
20 ± 6 
 
 
43 ± 3 
 
 
2.40 ± 0.02 
 
 
TiO2 coated, 
500 cycles 
 
22.7 ± 0.4 
 
 
8.7 ± 0.3 
 
 
19 ± 5 
 
 
44 ± 4 
 
 
2.39 ± 0.02 
 
 
Batch II 
Uncoated 
 
24.5 ± 0.5 
  
 
10.0 ± 0.8 
 
 
44 ± 8 
 
61 ± 7 
 
2.46 ± 0.05 
 
EPO coated, 
2 mg/cm2 
 
23.9 ± 0.5 
 
 
9.8 ± 0.9 
  
 
16 ± 2 
 
 
44 ± 3 
 
 
2.46 ± 0.02 
 
EPO coated, 
4 mg/cm2 
 
24.8 ± 0.6 
 
 
9.6 ± 0.6 
 
 
25 ± 3 
 
 
44 ± 4 
 
 
2.51 ± 0.04 
37 
 
 741 
 
Batch III 
Uncoated 
 
23.3 ± 0.5 
 
 
10.0 ± 0.6 
 
 
31 ± 3 
 
51 ± 3  
 
2.40 ± 0.03 
 
EPO coated, 
6 mg/cm2 
 
24.4 ± 0.6 
 
 
9.3 ± 0.4 
 
29 ± 4 
 
37 ± 2 
 
2.49 ± 0.03 
 
EPO coated, 
8 mg/cm2 
 
25.5 ± 0.6 
 
 
9.6 ± 0.8 
 
 
50 ± 3 
 
41 ± 3 
 
 
2.54 ± 0.02 
 
   
